Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway
(Q39680200)
scientific article published on 14 July 2010
scientific article published on 14 July 2010
Language: